Two thirds of families gave telephone consent to blood, lymph node, and liver samples being taken at postmortem examination and used as control samples in a study designed to validate tests for viral markers. The negative effect of media attention on postmortem retention of organ and tissues was small. The results compare with a 98.8% consent rate for use of surplus tissue in research among surgical patients from the same hospital trust.
3 These findings reinforce the notion that attitudes about using tissue from dead people are different from those about tissue from the living.
The attitudes of recently bereaved families in our study are similar to those described in qualitative research published by the Retained Organs Commission. 4 The commission's research found that most of the public support use of postmortem material for medical purposes and identified consent as an issue. A review from the NHS Centre for Reviews and Dissemination concludes that few data are suitable for inclusion in a systematic review of the psychological aspects of organ and tissue donation and suggests that primary research is a more suitable option.
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British hospitals and different versions of the Glasgow coma scale: telephone survey
Martin F Wiese
The Glasgow coma scale is a clinical scoring system for objectively assessing how conscious a patient is. Although limited for predicting functional outcome, 1 the scale is useful when making decisions about management in the acute setting, particularly for patients with traumatic brain injuries. Patients who score < 15 need imaging or observation, and patients with scores < 9 need to be promptly considered for definitive airways management. The original Glasgow coma scale, published in 1974, had 14 points.
2 Two years later, its authors introduced a distinction between "normal" and "abnormal" flexion (withdrawal to pain and decorticate response) increasing the "best motor response" item by one point.
Participants, methods, and results
I conducted a national observational study of the neurological observation charts used in hospitals which care for adult patients with traumatic brain injuries.
Using the 2001-2 directory of the British Association for Accident and Emergency Medicine, I identified all UK emergency departments which manage patients with traumatic brain injuries. We contacted a sister or charge nurse in each departments. Using a structured telephone interview, we asked staff to determine which version of the Glasgow coma scale they used by checking the neurological observation chart visually. We also asked the nurse to name one ward providing observation for patients with traumatic brain injuries, where we repeated the interview. Finally, we telephoned one ward in every specialist neurosurgical unit in the United Kingdom (table) .
Comment
The original, 14 point, Glasgow coma scale continues to be used in many British hospital units which manage patients with traumatic brain injuries. Many of the staff that we contacted were not aware that the version of the scale that they were using had been superseded.
The parallel use of two versions of the Glasgow coma scale in the United Kingdom has been virtually unnoticed, possibly because publication of the revised scale in 1976 was not accompanied by an explanation and did not result in a clarifying change of name.
No evidence has been published that the continued use of the 14 point scale may have caused harm to any patient. The practice does, however, lead to difficulties. Staff from one hospital told us about their recurrent problems communicating with the local neurosurgical unit because the two were using different scales. In another trust, the neurological observation charts were changed after a recent coroner's inquest: relatives of a patient who had died of severe traumatic brain injury had raised questions about the logic of two different versions of the Glasgow coma scale being used within the same trust.
Users of the Glasgow coma scale need training to ensure consistency and reliability of scoring.
5 The continued employment of two different scales can only add to the confusion. Although the 15 point Glasgow coma scale is not perfect, it should be used by everybody who manages patients with traumatic brain injuries until even better measures of consciousness are devised.
I thank D Wallis for help with the study design and E Glucksman and P Leman for their comments on the drafts. Many thanks also to all the hospital staff. Contributors: MFW wrote the paper and is guarantor. Nicola Burger collected some data. Funding: None. Competing interests: None declared. Doctors are poor at taking alcohol histories in many clinical settings. 1 2 Given the increasing prevalence of drug misuse in the general population and in psychiatric patients, the extent of detection of drug misuse is also important. For patients with comorbid substance misuse and psychiatric problems, the UK Department of Health states, "Individuals with dual problems deserve high quality, patient focused, and integrated care. This should be delivered within mental health services."
3 If substance misuse is not detected, however, such care is unlikely to be delivered. We examined data to investigate the prevalence of alcohol and drug misuse in inpatients admitted to psychiatric wards and the extent and accuracy of detection by the psychiatrists doing assessments on admission.
Participants, methods, and results
We aimed to approach all new admissions to six acute psychiatric wards in two London hospitals over three months. Patients who consented completed the alcohol use disorders identification test (AUDIT) and a short version of the substance abuse assessment questionnaire. 4 An AUDIT score ≥ 8 indicates hazardous alcohol use and ≥ 15 indicates alcohol dependence.
We excluded patients who did not speak English, who were admitted to the psychiatric intensive care unit, or who were younger than 18 or older than 75. We also excluded patients admitted to specialist wards for addiction or eating disorders and those admitted to forensic wards.
We studied case notes to determine whether a history of substance misuse had been recorded on current admission, its comprehensiveness, whether relevant investigations had been performed, and whether any screening tools had been completed. We considered alcohol and illicit drugs separately. A full history was one including the age of first misuse of each substance, and questions about problems related to using substances and symptoms of dependence, periods of abstinence, and use of specialist services. A partial history contained any one or more of these but less than a full history.
Of a total of 364 new admissions, 326 (89%) were eligible; we approached 263 patients, and 200 (76% of those eligible) gave consent. Not seeing patients was usually because they were admitted and discharged over a weekend or because they absconded.
Of the 200 patients who took part, 106 (53%) were men and 94 (47%) were women. Mean age was 41 years; 
